Kenny Weng

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes”.

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Nature Communications(2024)10.1038/s41467-024-51156-5

N/A

0.928DataRank · unranked

62 citations

Adam Presser, Richa Singh, Matthew A. Booker, Nicole A. Traphagen, Kenny Weng +15 more

Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0045

N/A

0.489DataRank · unranked

25 citations

Yasutaka Yamada, Kenny Weng, Osasenaga Idahor, Himisha Beltran, Varadha Balaji Venkadakrishnan

Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression

Cancer Research(2025)10.1158/0008-5472.can-25-0636

N/A

0.292DataRank · unranked

6 citations

Adam Presser, Nathaniel C.E. Voss, James Neiswender, Lisa Brenan, Keira Prenza Sosa +5 more

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Research Square(2024)10.21203/rs.3.rs-3935288/v1

N/A

0.241DataRank · unranked

4 citations

Adam Presser, Richa Singh, Matthew A. Booker, Nicole A. Traphagen, Kenny Weng +15 more

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Research Square(2024)10.21203/rs.3.rs-3935288/v2

N/A

0.165DataRank · unranked

2 citations

Adam Presser, Richa Singh, Matthew A. Booker, Nicole A. Traphagen, Kenny Weng +15 more